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The basal forebrain (BF) cholinergic system has an important role in attentive functions.
The cholinergic system can be activated by different inputs, and in particular, by
orexin neurons, whose cell bodies are located within the postero-lateral hypothalamus.
Recently the orexin-producing neurons have been proved to promote arousal and
attention through their projections to the BF. The aim of this review article is to
summarize the evidence showing that the orexin system contributes to attentional
processing by an increase in cortical acetylcholine release and in cortical neurons
activity.
Keywords: attention, orexin, basal forebrain, lateral hypothalamus, acetylcholine
INTRODUCTION
Attention may be defined as the behavioral and cognitive process that allows us to select the
information present in our environment on the basis of their relevance along with the ability to
ignore irrelevant stimuli (Sarter et al., 2001). It consists of several components such as sustained,
selective and divided attention, which are responsible for the control of the flow of information in
the cognitive system (Rieger et al., 2003). Attention involves both top-down processes (knowledge-
driven mechanisms) and bottom-up processes (mechanisms driven mainly by the characteristics
of the target stimulus and its sensory context; Sarter et al., 2001; Chieffi et al., 2004, 2012). These
two processes drive the attentive focus control (Gazzaniga et al., 2002). Attentional processing
comprises some generalized states of arousal which refers to the state of physiological reactivity
ranging from sleep to excitement or panic (Coull, 1998; Fadel and Burk, 2010).
Changes in arousal typically are deduced from brain activity data (EEG), whereas the study
of attention is based on behavioral studies. Moruzzi and Magoun (1949) first demonstrated that
cerebral activation is related to changes in EEG waves and has a brainstem origin. The discovery
and localization of the brainstem reticular arousal system (RAS) was subsequently made
by Moruzzi and Magoun (1949). The more evident arousal effect on EEG activity is the
‘‘desynchronization’’ phenomenon. It refers to the rapid shift from high-amplitude low-frequency
EEG activity, typical of sleep, to low-amplitude high-frequency electroencephalographic
activity, typical of wakefulness. EEG was the earliest measure used to systematically examine
human brain cortical activity. After a long period of decline in clinical interest, EEG is now
Frontiers in Behavioral Neuroscience | www.frontiersin.org 1 January 2017 | Volume 11 | Article 10
Villano et al. Orexin, BF and Attention: Possible Interactions
attracting increasing scientific and clinical interest. This
resurgence is due to ongoing advances in signal processing
and visualization that increase the spatial resolution of EEG
imaging and exploit its ability to image quick transient
cortical events and more precise regional changes in cortical
activity. For the last few decades, scalp channel EEG data
have been analyzed principally either in the time domain
via ERP trial averaging, or in the frequency domain using
FFT that estimate spectral power within a given frequency.
Although phenomena and definitions may vary, EEG spectral
power variations are typically dominated by distinct changes
in power in few frequency bands. The standard terminology
for these bands is: delta (<4 Hz), theta (4–7 Hz), alpha
(8–12 Hz), beta (13–25 Hz; often split into beta-1/sensorimotor
rhythm (SMR), 13–16 Hz, and beta-2, 17–25 Hz), and gamma
(25–50 Hz or even higher frequency broadband activity
extending to 200 Hz or greater). Cerebral activation is also
detected during rapid eye movement (REM) sleep. Experimental
evidence suggest that arousal systems work differently during
the wake state and the REM sleep (Krueger et al., 2016).
Arousal effects arise from the stimulation of the mesopontine
cholinergic nuclei (Montplaisir, 1975; Jones and Webster,
1988) and the locus coeruleus (LC; Steriade and McCarley,
1990), which consist principally of noradrenergic neurons.
Conversely, during REM the monoaminergic (noradrenergic
and serotoninergic) neurons are silent (Hobson et al., 1975;
McGinty and Harper, 1976). It is possible to distinguish brain
mechanisms involved in attention from arousal, thanks to
changes in task performance following manipulations known to
affect attention (De Gangi and Porges, 1990; Schiff and Plum,
2000; Fadel and Burk, 2010). In this case, the interpretation
of data resulting from these manipulations is primarily based
on behavioral performance data (e.g., detection rates, false
alarm rates, etc.) (Sarter and Bruno, 1999; Sarter et al., 2001).
The relationship between arousal and attention is not simple.
Attentional performance improves with a moderate increase
of arousal but drops dramatically during high excitement
state (Easterbrook, 1959). On the other hand, sustained
attention reduces arousal and induces drowsiness (Babkoff et al.,
1991).
Furthermore, physiological studies and data collected on
patients suffering from injuries or neurological diseases provide
a wealth of information on the neural mechanisms of attention
processes. Thus, it is important to determine the brain networks
mediating attention both to understand the neural mechanisms
underlying these cognitive functions to expand knowledge on
neurodevelopmental disorders characterized by impairments
in attentional functions (Sarter et al., 2001; Esposito and
Carotenuto, 2010, 2014; Carotenuto et al., 2016). Among
these networks, the basal forebrain (BF) cholinergic system
is considered as a major component of top-down processes
in the mediation of attention, it is known to play a role in
several aspects of attentional function (Fadel and Burk, 2010;
Viggiano et al., 2014) and to be necessary for normal attentional
performance (Sarter et al., 2001; Boschen et al., 2009). This
system can be activated by different afferent inputs and can
influence how attentional resources are allocated (Chieffi et al.,
2009; Fadel and Burk, 2010). Among the various afferent inputs
to the BF cholinergic projection system, the hypothalamus
represents an important source of projections. The available
data demonstrate that orexin neurons, whose cell bodies are
present in the lateral hypothalamus, contribute substantially
to these projections (Cullinan and Záborszky, 1991). Orexin
neurons have widespread projections to a number of brain
regions, including cholinergic BF structures. In the last decade,
several studies have focused on specific neuronal pathways
through which the orexin-producing neurons may promote
not only arousal, but also attention. Their results suggest
that the basal forebrain may be a key site through which
these neurons act. In this article, we review the effects of
orexin-producing neurons and their projection to the BF to
support the hypothesis that orexin system may contribute to
attentional processing through increased cortical-acetylcholine
(Ach) release.
THE CHOLINERGIC BASAL FOREBRAIN
SYSTEM
In the BF, cholinergic neurons are codistributed with several
other cell populations, including GABAergic and various
neurons containing calcium binding protein for example
calbindin, calretinin or parvalbumin (Fadel and Burk,
2010). These neurons project to all areas and layers of the
cortex (Sarter and Bruno, 1997). The cholinergic projections
modulate the response of pyramidal cells to other cortical-
glutamatergic inputs (McCormick, 1993), facilitating the
bottom-up sensory information processing within the cortex
(Figure 1; Muir et al., 1994; Sarter et al., 2001). Furthermore,
the long radiating dendrites of the cholinergic BF neurons
receive inputs from all the brainstem and hypothalamic
arousal systems, for example cholinergic ponto-mesencephalic
neurons, noradrenergic LC neurons, dopaminergic ventral-
mesencephalic neurons, histaminergic tubero-mammillary
neurons and orexinergic perifornical neurons (Jones and
Cuello, 1989; Panula et al., 1989; Zaborszky and Cullinan, 1996;
Peyron et al., 1998; Semba et al., 1998).
The cholinergic basal forebrain neurons have been implicated
in mechanisms of synaptic plasticity, learning, memory, arousal
and attention (McCormick, 1993; Leanza et al., 1996); all
these functions are related to cortical activation (Jones, 2003).
For instance, pharmacological manipulations of cholinergic
receptors in extra-striate occipital and superior-medial parietal
cortices affect attentional performance (Bentley et al., 2004), and
lesions of the BF inmonkeys also interfere with attention (Voytko
et al., 1994).
The cholinergic basal forebrain neurons are hyperpolarized
by ACh released by brainstem or forebrain neurons; both
muscarinic and nicotinic receptors are involved in this effect,
and could modulate the cortical and forebrain activity during
particular states across the sleep–waking cycle (McCormick,
1993; Khateb et al., 1997). In the cerebral cortex and in the
hippocampus, Ach release is maximal during wakefulness and
REM sleep (Jasper and Tessier, 1971; Marrosu et al., 1995),
while it decreases during non-REM sleep (Arrigoni et al., 2010).
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FIGURE 1 | Overview of the basal forebrain (BF) cholinergic pathway. The BF cholinergic system of the Sprague-Dawley rats includes the medial septum (MS),
vertical limbs of the diagonal band of Broca (vDB), nucleus basalis of Meynert (NBM), and substantia innominate (SI). The vDB and NBM have diffuse projections to
all parts of the neocortex and to basolateral amygdala and olfactory bulb (these latter two are not shown here). The MS and vDB project to hippocampus. Besides,
the brainstem cholinergic system projects to the thalamus and hypothalamus but also to the BF region. This system includes the pedunculopontine tegmental
nucleus (PPT) and laterodorsal pontine tegmentum (LDT).
Inglis et al. (1994) suggested that the BF neurons may be
involved, together with dopaminergic neurons, in the regulation
of attention and in rewarding activities including food intake
because high amount of Ach is released during eating. Many
other neurotransmitters can excite the BF neurons, for example
glutamate (Khateb et al., 1995a), noradrenaline (NA; Fort et al.,
1995), histamine (Khateb et al., 1995a,b), orexin (Eggermann
et al., 2001), or can inhibit them for example serotonin (Khateb
et al., 1993).
OVERVIEW OF THE OREXIN NEURONS
The orexin/hypocretins are neuropeptides synthesized by a
cluster of neurons within the postero-lateral hypothalamus that
produce excitatory effects on target neurons. Two independent
research groups discovered simultaneously these neuropeptides
in the late 1990s. One group named these peptides orexins,
from the Greek word ‘‘orexis’’, meaning ‘‘appetite’’, because
they seemed to be involved in the control of feeding and
metabolism (Sakurai et al., 1998; Sakurai, 2007). The other
group named these peptides hypocretins, because these peptides
share significant sequence homology with the members of
the glucagon/vasoactive intestinal polypeptide/secretin (incretin)
family (de Lecea et al., 1998). Therefore, as hypocretin, de Lecea
et al. (1998), intended to indicate a hypothalamic member of
the incretin family. However, the terms are interchangeable in
the literature. Orexin-A (orexin-A/hypocretin-1, Orx-A) and
orexin-B (orexin-B/hypocretin-2, Orx -B) are cleaved from a
single gene product, prepro-orexin (Sakurai et al., 1998). Orexins
act on two different G-protein coupled receptors: orexin 1
receptor (Orx1R), which binds selectively Orx A, and orexin
2 receptor (Orx2R), which binds both Orx-A and Orx-B
with equal affinity (Sakurai et al., 1998; Sakurai, 2007).
Orexin neurons also release other neurotransmitters, such as
glutamate on histamine tubero-mammillary neurons (critical
for the maintenance of arousal), the inhibitory neuropeptide
dynorphin (which also modulate appetite) and pentraxin
(regulator of AMPA receptors clustering; Chou et al., 2001;
Reti et al., 2002; Schone et al., 2012). The orexin neurons
may integrate a variety of interoceptive and homeostatic
signals related to environmental, physiological and emotional
stimuli to promote wakefulness and behavioral arousal in
response to emotions, stress, hunger and circadian rhythms
(Yoshida et al., 2006; Viggiano et al., 2009). Furthermore
several brain regions involved in the central regulation of
autonomic and endocrine processes or attention are targets
of extensive orexin projections (Horvath et al., 1999; Chieffi
et al., 2014a,b). Neurons containing the neuropeptide orexin
send axons to numerous regions, throughout the central
nervous system; their projections are widely distributed in
the brain (Chemelli et al., 1999). These neurons innervate
all brain regions known to promote wakefulness and arousal
(Saper et al., 2005) including the cerebral cortex, BF, tubero-
mammillary nucleus (TMN), LC, and dorsal raphe (DR;
Peyron et al., 1998; Yoshida et al., 2006). Furthermore, they
innervate brain nuclei that regulate motivation and emotions
(Sakurai and Mieda, 2011; Thompson and Borgland, 2011; Di
Bernardo et al., 2014), and brain regions that regulate motor
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and autonomic functions (Nattie and Li, 2012). Thus, the
orexin system is anatomically well positioned to coordinate
many aspects of arousal and attention (Alexandre et al., 2013).
Indeed, the orexin neurons are important in regulation of
sleep/wakefulness states and lack of the peptide or the receptor
caused narcolepsy in humans, dogs and mice (Chemelli et al.,
1999; Lin et al., 1999; Thannickal et al., 2000).
OREXIN AND ATTENTION
In attention regulation, orexins play a significant role likely
via interactions with multiple ascending neuromodulatory
systems, including dopamine neurons in the ventral midbrain
(Vittoz and Berridge, 2006), noradrenergic neurons in the
LC (Horvath et al., 1999; Espana et al., 2005) and the
basal forebrain cholinergic system (Fadel and Burk, 2010).
In the BF, orexin peptides increase cell activity and Ach
release, thus they modulate attentional mechanisms (Fadel and
Burk, 2010). Attentional deficits present in neurodegenerative
conditions such as Alzheimer’s disease, schizophrenia, drug
addiction, and age-related cognitive decline may be related
with alterations in the interactions between orexin neurons and
cortical ACh neurons (Fadel and Burk, 2010). An imbalance
in orexin regulation may also be involved in the pediatric
Attention Deficit Hyperactivity Disorder syndrome (ADHD),
comprising cognitive alterations, and in narcoleptic and/or
obese and/or migrainous subjects as summarized in the Prader-
Willi syndrome (Cortese et al., 2008; Carotenuto et al., 2009;
Verrotti et al., 2013, 2015a,b; Morandi et al., 2015; Miano
et al., 2016). Orexin neurons activity varies with the degree
of arousal and is linked to heightened attentional states. Their
activity promotes arousal, with maximal discharge during active
wakefulness (Lee et al., 2005; Mileykovskiy et al., 2005; Viggiano
et al., 2010), while their discharge decreases during quiet waking,
in the absence of movement, and are silent in slow wave
sleep and tonic periods of REM sleep, with occasional burst
of activity during REM sleep (Lee et al., 2005; Mileykovskiy
et al., 2005). In addition to arousal, orexins promote eating
and are likely to have a role in physiological functions such
as regulation of blood pressure, the neuroendocrine system,
body temperature, and energy homeostasis (Peyron et al.,
1998; Hara et al., 2001; Jones, 2003; Messina et al., 2014).
Blouin et al. (2013) demonstrated that, in the human brain,
Orx-A levels are maximal during positive emotion, social
interaction, anger and increase at wake onset, suggesting
that these levels are linked to specific emotions and state
transitions.
NETWORK REGULATION OF OREXIN
NEURONS
Orexin neurons are controlled by positive and negative feedback
mechanisms mediated by the lateral hypothalamus/perifornical
area (LH/PFA; Figure 2). The Orx2R, Orx-A or Orx-B form
a positive-feedback loop which opens nonselective cation
channels and depolarizes orexin neurons and modulates
presynaptic glutamate release (Yamanaka et al., 2010). Indirectly,
glutamatergic transmissions stimulate orexin neurons through
glutamate activation of astrocytes that release lactate and
protons into the extracellular space through monocarboxylate
transporters (MCTs; Pellerin et al., 1998; Burt et al., 2011).
Furthermore, to sustain physical activity, orexin neurons
metabolize astrocyte-derived lactate as an energy source;
moreover, the release of protons due to MCT activity
causes a local decrease in extracellular pH that can result
in depolarization of orexin neurons (Williams et al., 2007).
Even adenosine triphosphate (ATP), released by astrocytes and
neurons, has an excitatory effect on orexin neurons through
the ionotropic P2X receptors (Wollmann et al., 2005). ATP
can be hydrolyzed by ectonucleotidases releasing adenosine
in the extracellular space (Wall and Dale, 2008) which
inhibits voltage-gated Ca2+ currents in orexin neurons leading
to their inhibition (Liu and Gao, 2007). Negative feedback
pathways have also been identified, for example Dynorphin
and Nociceptin/Orphanin FQ (N/OFQ), either co-expressed by
orexin neurons (Chou et al., 2001; Maolood and Meister, 2010).
Dynorphin attenuates glutamate release acting on presynaptic
excitatory terminals, while N/OFQ inhibits both excitatory and
inhibitory transmission (Li and van den Pol, 2006). The balance
between the excitatory and inhibitory effects determines the
activity levels of the postsynaptic cell (Burt et al., 2011). In
addition, the glutamate released synaptically creates a negative
feedback loop acting on presynaptic autoreceptors to inhibit
glutamate and GABA released through group III metabotropic
glutamate receptors (mGluRs; Acuna-Goycolea et al., 2004).
Even other distinct neuronal populations in the LH/PFA create
synaptic contacts with orexin neurons for example neurons
expressing melanin concentrating hormone (MCH) and leptin
receptor-expressing (LepRb+) neurons. The MCH neurons form
reciprocal connections with orexin neurons and are directly
depolarized by Orexin A and B which stimulate presynaptic
glutamate release, whereas dynorphin and N/OFQ directly
induce hyperpolarization of MCH neurons (Li and van den
Pol, 2006). MCH can reduce the presynaptic glutamate release
induced by orexin receptors to antagonize the excitatory effects
on orexin neurons (Rao et al., 2008). Leptin receptor-expressing
(LepRb+) neurons are excited by leptin and use GABA as
a neurotransmitter (Leinninger et al., 2009). Leptin inhibits
orexin neurons through hyperpolarization of these neurons
(Yamanaka et al., 2003), because the activation of the LepRb+
neurons produces an inhibition of orexin neurons (Burt et al.,
2011). Orexin neurons are also innervated by afferents of
non-cholinergic terminals from the BF cholinergic cell area.
BF glutamatergic neurons can excite orexin neurons involved
in arousal, whereas GABAergic neurons can inhibit orexin
neurons promoting behavioral quiescence and sleep (Henny
and Jones, 2006). In summary, different peptides released by
orexin neurons or distinct populations of LH/PFA neurons
modulate orexin neurons and exert different excitatory and
inhibitory influences during wake or sleep states. Others studies
showed that LC neurons have an important role in waking
and REM sleep (REMS; Mallick et al., 2012; Choudhary et al.,
2014). Kumar et al. (2012) have constructed a mathematical
model of waking, NREMS and REMS, showning the importance
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FIGURE 2 | Regulation of orexin neurons. Orexin neurons activity is controlled by positive and negative feedback mechanisms mediated by neurotransmitters
released by lateral hypothalamus/perifornical area (LH/PFA) neurons. Orexin neurons corelease excitatory neurotransmitters orexin and inhibitory transmitters
dynorphin (Dyn) and nociceptin/orphanin FQ (N/OFQ). (A) Direct effect: all of neurotransmitters coreleased by Orexin neurons form a feedback which directly affects
postsynaptic orexin neurons. (B) Synaptic modulation: orexins modulate presynaptic glutamate release at excitatory synapses. Besides, Dyn attenuates glutamate
release acting on presynaptic excitatory terminals, while N/OFQ inhibits both excitatory and inhibitory transmission. The balance between the excitatory and inhibitory
effects determines the activity levels of the postsynaptic cell. (C) Indirect effects: Regulation of orexin neurons by astrocytes: Glutamate activates astrocytes which
release lactate (Lac) and protons (H+) into the extracellular space through monocarboxylate transporters (MCTs). Orexin neurons metabolize astrocyte-derived lactate
as an energy substrate to sustain activity. Furthermore, extracellular pH decreases due to MCT activity resulting in depolarization of orexin neurons. (D) Adenosine
triphosphate (ATP) effects: ATP released by astrocytes and neurons, stimulates orexin neurons depolarizing them through the ionotropic P2X receptors.
Ectonucleotidases hydrolyze ATP releasing into adenosine in the extracellular space which inhibits orexin neurons. (E) Autoinhibition: the glutamate released
synaptically creates a negative feedback loop acting on presynaptic autoreceptors to inhibit glutamate release. (F) Melanin concentrating hormone (MCH) neurons
are directly depolarized by Orexin A and B which stimulate presynaptic glutamate release, whereas dynorphin and N/OFQ induce direct hyperpolarization of MCH
neurons. (G) Leptin receptor-expressing GABAergic neurons are excited by leptin and use GABA as a neurotransmitter. Leptin inhibits indirectly orexin neurons by
activating these inhibitory LepRb+ neurons. In summary, the balance between the excitatory and inhibitory effects determines the activity levels of the orexin neurons.
Glut, glutamate; (+), stimulation; (−) inhibition.
of orexinergic neurons in stabilizing the wake-sleep cycle
and demonstrating that even small changes in inputs to or
from those neurons can have a large impact on the ensuing
dynamics. The results from this model help to understand
the neural mechanisms of regulation and the patho-physiology
of REMS.
MODULATION OF THE BASAL FOREBRAIN
CHOLINERGIC SYSTEM BY OREXIN
NEURONS: EFFECTS ON ATTENTION
Orexin Receptors in the Basal Forebrain
Orexin neurons have widespread projections to the basal
forebrain that may promote arousal by activating the cortex.
Orexin neurons also project onto BF cholinergic neurons and
release orexins in the BF. BothOrx1R andOrx2R are expressed in
the BF, and can activate cholinergic afferents (Marcus et al., 2001)
and narcoleptic dogs lack OX2R (Lin et al., 1999). However,
there are conflicting results from in vitro electrophysiological
studies and BF orexin administration with regard to what type
of orexin receptor subtypes are involved in the activation of
cholinergic fibers. in vitro electrophysiological data indicate that
both Orx-A and Orx-B can excite BF cholinergic cells, and
that their effects are primarily Orx2R-mediated (Eggermann
et al., 2001; Gotter et al., 2016). On the other hand, other
studies suggested that the effects of orexin administration in the
BF are primarily Orx1R-mediated (Espana et al., 2001). Using
mice lacking orexin receptors, Alexandre et al. (2012) found
that focal restoration of Orx1R and Orx2R in the substantia
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innominate (SI) partially rescued their ability to produce long
bouts of wakefulness. Furthermore, Boschen et al. (2009) have
blocked in rats the Orx1Rs through the administration of the
Orx1R antagonist SB-334867 prior to a two-lever sustained
attention task performance. Their results showed that Orx1R
blockade decreased the accuracy in attention-demanding tasks
and that some of these effects on attention may be mediated
by BF corticopetal neurons. In summary, the two receptors
may play different and complementary roles in response to
varying types of homeostatic challenges (Fadel and Frederick-
Duus, 2008).
Orexin Activation of the Basal Forebrain
Different in vitro studies have tried to understand how orexin
neurons activate the BF focusing primarily on the effects of
orexins on medial septum (MS) neurons that project to the
hippocampus and to the cortically projecting neurons of the
BF. In the MS, orexins directly excite septo-hippocampal
cholinergic neurons through the activation of the sodium,
calcium exchanger and inhibition of potassium channels,
presumably an inward rectifier, increasing hippocampal
acetylcholine release and promoting arousal (Wu et al.,
2004). Orx-A excites BF cholinergic neurons inducing cortical
release of acetylcholine and increasing attention (see Figure 3;
Arrigoni et al., 2010). Cortical acetylcholine levels increase
even more under demanding attention tasks (Hasselmo and
McGaughy, 2004) and orexin neurons increase firing to
promote arousal and during exploratory behaviors in response
to salient external stimuli (Mileykovskiy et al., 2005). It is
also important to consider that local application of orexins
to the BF promotes wakefulness and improves cognitive
performance. In fact, the administration of orexins into the
BF excites cholinergic neurons that release acetylcholine
in the cerebral cortex and thereby promotes wakefulness
(Eggermann et al., 2001; Espana et al., 2001; Fadel et al.,
2005). Within the prefrontal cortex, orexins can also directly
improve attentional processes relevant to executive aspects
of attention. Lambe et al. (2005) demonstrated that infusions
of Orx-B into the prefrontal cortex improved accuracy under
high attentional demand by exciting the same thalamo-
cortical synapses that are activated by acetylcholine from
the BF. Thus, through an increased cortical acetylcholine
release and a direct action on thalamo-cortical projections,
orexins may promote cortical activation and attention.
Orexin A can also modulate cholinergic neuron activity
indirectly, because it increases local glutamate release within the
basal forebrain. Indeed, Fadel and Frederick-Duus (2008)
demonstrated that the administration of Orx-A in the
BF increases local glutamate efflux. Furthermore, via an
excitatory autoreceptor mechanism, Orx-A might increase
BF glutamate release. Even non-cholinergic neurons of the
BF may be excited by orexins, for example most of the
GABAergic neurons of the BF (Fadel and Frederick-Duus,
2008; Arrigoni et al., 2010). In fact, orexin excites GABAergic
neurons of the MS that project to the hippocampus (Wu
et al., 2004) and GABAergic neurons of the magnocellular
preoptic nucleus and substantia innominata (MCPO/SI;
Blanco-Centurion et al., 2006). Blanco-Centurion et al.
(2006) studied the relative contribution of non cholinergic
neurons to arousal; they found that after selective lesion
of the basal forebrain-cholinergic neurons in the rats., the
microinjection of Orx-A into the BF increased waking and
still promoted arousal; this finding indicates that cholinergic
neurons are not essential for the effects of Orx-A and, thus,
suggests that Orx-A acts also on non-cholinergic neurons
(Blanco-Centurion et al., 2006). These findings suggest
that orexins may contribute to attentional processing in
the BF, not excluding, however, that other neural circuits
outside the BF may contribute to these effects (Boschen et al.,
2009).
Orexin, Circulating Factors and Basal
Forebrain
Orexin neurons are responsive to circulating factors related
to metabolic state, for example low plasma glucose, and are
activated by food deprivation (Cai et al., 1999). It has been
suggested that these neurons can provide a crucial regulation
of arousal level in response to signals of energy balance,
such as blood glucose, leptin, and food intake (Yamanaka
et al., 2003; Esposito et al., 2014; Messina et al., 2014).
Furthermore, Frederick-Duus et al. (2007) demonstrated that the
administration of the toxin orexin B–saporin (which produces
loss of orexin neurons in the LH/PFA) in food-restricted rats
lead them to be insensible to the cholinergic response to
presentation of palatable food. Moreover, animals pretreated
with the Orx1R antagonist, SB-334867, show an increased
feeding latency demonstrating that Orx1R activity is required
for an appetitive food stimulus to increase cortical Ach released.
Fadel and Frederick-Duus suggest that orexins are necessary
for the activation of BF cholinergic neurons in response to a
food-related stimulus and they are important for biasing the
allocation of attentional resources toward cues related to the
physiological status (Fadel and Frederick-Duus, 2008).
Influence of Other Orexin Neuron
Neurotransmitters on the Basal Forebrain
To better understand how orexin-producing neurons promote
cortical activation, some studies have focused also on the
neuropeptide dynorphin, which is synthesized in orexin neurons
and have specific effects on different classes of BF neurons.
Cholinergic neurons do not respond to dynorphin but are
directly excited by Orx-A, but there are two more populations
of non-cholinergic BF neurons. One of these populations is
excited by Orx-A and do not respond to dynorphin; the
other population of non-cholinergic sleep-promoting neurons,
is inhibited by dynorphin but do not respond to Orx-A
(Arrigoni et al., 2010). Therefore, the co-release of orexins
and dynorphin can activate a synergistic mechanism that
excites cholinergic and non-cholinergic wake-active neurons
and inhibits non-cholinergic sleep-active neurons promoting
attention and improving cognitive performance. In addition
to dynorphin, orexin neurons also co-release glutamate that
acts synergistically to excite BF via presynaptic glutamatergic
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FIGURE 3 | Pathways through which orexin could activate the BF to promote attention. In response to salient stimuli, orexin neurons produce several
neuropeptides which promote cortical activation and attention by acting on cholinergic and non-cholinergic neurons. Arrows indicate excitatory inputs; dots indicate
inhibitory inputs.
mechanisms (Arrigoni et al., 2010; Fadel and Burk, 2010). Orexin
neurons express also the neuronal activity-regulated pentraxin
(Narp) that is involved in clustering of glutamatergic α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors
(Reti et al., 2002) and may potentiate pre- or post-synaptic
responses to glutamate (Arrigoni et al., 2010). Despite the
need of more studies to understand the role of dynorphin,
glutamate and NARP, targeted deletion of orexin seem to have
different functional deficits than those induced by selective
ablation of orexin neurons (Chemelli et al., 1999; Hara et al.,
2001; Reti et al., 2002) suggesting that other secreted signaling
molecules expressed in these neurons are involved in their
effects.
Involvement of the Orexin-Basal Forebrain
Interactions in Narcolepsy
Narcolepsy is a disease characterized by excessive daytime
sleepiness, sleep paralysis, instability of sleep onset and REM
periods, and cataplexy (Weinhold et al., 2014). Reduced
orexinergic function, due to a reduction of orexin peptides,
or orexin neurons, or orexin receptors, is assumed to be a
major cause of narcolepsy, clearly demonstrated by post mortem
studies (Arrigoni et al., 2010). Neuropsychological impairments
have been found in narcoleptic patients, for example a
reduced performance in attention-demanding tasks (Fulda and
Schulz, 2001). Some studies suggest that narcoleptic patients
show deficits in attention even during normal wakefulness
periods (Rieger et al., 2003). Furthermore, BF degeneration is
associated with canine narcolepsy suggesting that a postsynaptic
degeneration and, in turn, impaired ACh-dependent cognitive
function may be caused by a deficit in orexin stimulation
(Siegel et al., 1999; Fadel and Frederick-Duus, 2008; Monda
et al., 2014). In human narcolepsy there are deficits in
selective processing of relevant stimuli. It is possible that these
deficits are due to a reduction in BF cholinergic signaling to
the cortex (Fadel and Burk, 2010). Weinhold et al. (2014)
have investigated the effect of intranasal administration of
Orx-A in narcoleptic patients with cataplexy on sleep behavior
and cognitive functions. In the test of divided attention
these patients showed enhanced performances after orexin-A
administration, as indicated by their mean reaction time
and fewer false reactions. Their results confirmed the role
of Orx-A as a REM sleep stabilizing factor and provided
functional evidence for the Orx-A effects on attention in
narcolepsy with cataplexy (Weinhold et al., 2014). Other studies
demonstrated that the intranasal administration of Orx-A in
sleep-deprived rhesus monkey is able to relieve the cognitive
deficits produced by the loss of sleep (Deadwyler et al., 2007).
Moreover, it has been suggested that nasal Orx-A administration
may be an effective approach to the treatment of orexin
deficiency in narcolepsy (Peyron et al., 2000; Thannickal et al.,
2000).
CONCLUSION
Collectively, the available data strongly support the hypothesis
that orexin stimulation of the BF is able to promote
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cortical activation and attention by acting on cholinergic and
non-cholinergic neurons in response to salient stimuli. In
fact, orexins excite cholinergic neurons, thus the increase in
acetylcholine release within the cerebral cortex contributes
to the cortical activation associated with attention. We have
reviewed evidence suggesting that the BF may be a key target
through which orexin neurons promote attention, even if many
questions remain to be answered. Defining if orexin signaling
in the BF is sufficient to maintain attention and the interaction
between orexin and dynorphin within the BF should provide
novel data to explain the role of orexin in several aspects of
attention.
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